CompTalk: COVID-19 — The Race for a Cure

A COVID-19 cure is needed for life to go back to normal, but just how close are we?
By: | October 30, 2020
Phil Walls discusses a COVID-19 cure

If there’s one thing today that unites people of every continent, it is the desire for a cure for COVID-19.

Rarely before the pandemic had people from nearly every country around the world awaited the same thing. But now, with life on hold and economies faltering, everyone knows that we need a cure for life to return to normal.


This can’t happen, however, until either a vaccine is developed and distributed or a drug is found to effectively treat the virus.

In this CompTalk, brought to you by the National Workers’ Compensation and Disability Conference — National Comp — Phil Walls, chief clinical officer at myMatrixx, takes listeners on the race for a COVID-19 cure, detailing how both the pandemic and political factors have influenced drug and vaccine development along the way.

“There was a flurry of activity at the NIH regarding drug development,” Walls said during the presentation.

“The National Institutes of Health is not an organization that I usually link to phrases like, ‘a flurry of activity.’ ”

The talk brings listeners back to the smallpox pandemic of the 1700s and details how inoculation was eventually achieved while drawing parallels to our present crisis.

It also delves into how our modern drug development system — with its multiple trials and clinical reviews — was developed and how, despite how desperately we all want a COVID-19 cure, it is a process that can’t be rushed.

You can view the session on-demand here&

CompTalks are short-format educational presentations by the National Comp conference that fit our busy schedules, delivered by voices throughout the industry.

This series will offer a mix of thought-provoking opinions, insider perspectives and useful strategies you can bring back to your team to spark further discussion — presented on-demand.

This new feature is a complement to the 2020 National Comp Digital Program, which included a One-Day Virtual Event on Oct. 21, and an ongoing Digital Session Series set to launch on Nov. 5.

Courtney DuChene is an associate editor at Risk & Insurance. She can be reached at [email protected]

More from Risk & Insurance

More from Risk & Insurance